ILDSTAD SUZANNE (Chief Scientific Officer) sold 3.6% of their position (141.06K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $342.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/9/2023ACC: 0001209191-23-035984
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-141.06K
Net shares
Net seller
$342.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
141.06K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−75K
Price / share
$2.39
Trade value
$179.09K
% of position
1.9%
6/7/2023
3.96M→3.88M
Common Stock
Direct
Shares
−40.64K
Price / share
$2.48
Trade value
$100.77K
% of position
1.0%
6/8/2023
3.88M→3.84M
Common Stock
Direct
Shares
−25.42K
Price / share
$2.46
Trade value
$62.64K
% of position
0.7%
6/9/2023
3.84M→3.82M
Total
Net shares
−141.06K
Net value
-$342.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2023 | S · Sale | −75K | $2.39 | $179.09K | 1.9% | 3.96M | 3.88M |
| Common Stock Direct | 6/8/2023 | S · Sale | −40.64K | $2.48 | $100.77K | 1.0% | 3.88M | 3.84M |
| Common Stock Direct | 6/9/2023 | S · Sale | −25.42K | $2.46 | $62.64K | 0.7% | 3.84M | 3.82M |
| Total | −141.06K | -$342.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Total
1.31M indirect1.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 1.31M | 1.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported